Article thumbnail

Specific feasibility metrics used in selected studies.

By Temitope Ojo (6391868), Lynette Lester (6391871), Juliet Iwelunmor (770171), Joyce Gyamfi (3293661), Chisom Obiezu-Umeh (6391874), Deborah Onakomaiya (6391877), Angela Aifah (3805093), Shreya Nagendra (6391880), Jumoke Opeyemi (6391883), Mofetoluwa Oluwasanmi (6391886), Milena Dalton (6391889), Ucheoma Nwaozuru (6391892), Dorice Vieira (6391895), Gbenga Ogedegbe (530876) and Bernadette Boden-Albala (6391898)


<p>Specific feasibility metrics used in selected studies.</p

Topics: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Virology, implementation science methodology, feasibility, LMIC, scoping review Background Integrated, Conclusions Integrating CVD, CVD-HIV care, 3 conferences abstracts, CVD-HIV care interventions, NCD
Year: 2019
DOI identifier: 10.1371/journal.pone.0212296.t002
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.